Ains-To audit the content of primary cutaneous malignant melanoma histopathology reports with special reference to Breslow thickness and lateral excision margins. Methods-The Trent Regional Cancer Registry was asked to provide details ofprimary cutaneous malignant melanomas for the most recent year available (1990). Histopathology departments were then requested to provide copies of the relevant reports, which were then analysed. Results-In total, 178 reports were obtained from 16 departments. Breslow thickness was present in 87-1% (155/178) and a comment had been made on lateral excision in 85-4% (1521178). A specific clearance measurement was recorded in 5-6% (10I178), and in 9-6% (17/178) tumour was stated to extend to the margin. In 4-5% (8/178) neither thickness nor a comment on excision was recorded. Clinical advice on excision was offered in 12-4% (22/178). A macroscopic description was absent in 6-7% (12/178). Conclusions-Deficiencies were identified in the quality of malignant melanoma histopathology reports in Trent Region. There is no reason to believe that significant improvements have occurred since 1990 or that other regions are performing differently. A national standard for reporting primary cutaneous malignant melanoma is recommended. As a minimum, all reports should include Breslow thickness and a specific measurement of lateral clearance. This will facilitate prognostic evaluation, clinical management and audit. This standard would not exclude the reporting of other information, depending on local policy. As with all standards, continual review must be undertaken and consideration given as to whether other more recent parameters, such as growth phase, also warrant future inclusion.
5-6% (10I178), and in 9-6% (17/178) tumour was stated to extend to the margin. In 4-5% (8/178) neither thickness nor a comment on excision was recorded. Clinical advice on excision was offered in 12-4% (22/178). A macroscopic description was absent in 6-7% (12/178). Conclusions-Deficiencies were identified in the quality of malignant melanoma histopathology reports in Trent Region. There is no reason to believe that significant improvements have occurred since 1990 or that other regions are performing differently. A national standard for reporting primary cutaneous malignant melanoma is recommended. As a minimum, all reports should include Breslow thickness and a specific measurement of lateral clearance. This will facilitate prognostic evaluation, clinical management and audit. This standard would not exclude the reporting of other information, depending on local policy. As with all standards, continual review must be undertaken and consideration given as to whether other more recent parameters, such as growth phase, To date, the content of malignant melanoma histopathology reports has largely depended upon the enthusiasm ofindividual pathologists, combined with the requirements of local clinicians. For well over a decade, however, there has been a widespread consensus of opinion that at least two items of information are essential to assess the prognosis and management of stage I primary cutaneous malignant melanoma. These are tumour thickness, as originally defined by Breslow,' and information pertaining to excision margins.2 It is therefore significant that the Health of the Nation3 proposals relating to skin cancer specifically refer to the audit of tumour depth and width of excision.
During Advisory Forum discussions for Trent Region's skin cancer Health Gain Investment Programme, concern was expressed by some members that such essential information may not be routinely recorded in all malignant melanoma histopathology reports. Consequently, we decided to audit the contents of primary cutaneous malignant melanoma histopathology reports, with special reference to tumour depth and excision margins. It was hoped that the information gained would encourage further audit and, if necessary, improve the histopathological reporting of malignant melanoma. It was also envisaged that the results would serve as a baseline for the proposed Health of the Nation studies. The completed forms were checked independently GM) before data entry. After entry, the data set was verified on screen by one of the authors GM) and a research assistant. Analysis was performed using EPI-INFO, a public domain software package for epidemiology and disease surveillance.
Methods
Ethical approval was not sought as it was planned that only aggregated patient data would be provided in the final report.
Results
In total, 268 cases were on record in the Trent Cancer Registry for 1990. The registered patients originated from 27 hospitals and the reports had been issued by 17 histopathology departments. Copy reports were requested from all departments and replies were received from 16; 230 copy reports were received.
Forty one cases were excluded as they comprised a mixture of metastatic cutaneous melanomas, non-cutaneous melanomas, wider excision specimens, benign melanocytic naevi, and a small number of unrelated conditions. In total, there were 189 reports of primary cutaneous malignant melanoma and all contained a clear definitive diagnosis. Eleven of these were in situ melanoma and were excluded from further analysis. The have already stated their intention to re-audit the subject after a 12 month period.
In conclusion, details of Breslow thickness and excision margins should be included in all reports of primary cutaneous malignant melanoma and we recommend that this constitutes the current standard for audit purposes. Other information in reports, depending on local requirements, can also be useful and histopathologists may also wish to audit these. Furthermore, as with all standards, continual review must be undertaken and consideration given as to whether more recent parameters, such as growth phase, warrant inclusion. 
